Press Releases

February 23, 2023 | Press Release | Claims Rejection

All Claims Rejected for Universitätsspital Basel US Patent Application Describing MDMA to Enhance Emotional Effects of Psychedelics

USPTO directly cites prior art included in Porta Sophia's third-party preissuance submission in establishing application's lack of novelty and non-obviousness

February 23, 2023 | 3rd Party Submission

Mind Medicine, Inc U.S. Patent Application Two, "PSYCHDELICS FOR TREATMENT OF PAIN," Porta Sophia Files Third Party Submission

Psychedelic prior art library presents eight documents challenging patentability of all claims

February 23, 2023 | 3rd Party Submission

Mind Medicine, Inc U.S. Patent Application One, "PSYCHDELICS FOR TREATMENT OF PAIN," Porta Sophia Files Third Party Submission

Psychedelic prior art library presents seven documents challenging patentability of all claims

February 23, 2023 | 3rd Party Observation

Mind Medicine, Inc International Patent Application, Porta Sophia Files Third Party Observation

Psychedelic prior art library presents four documents challenging patentability of 23 application claims

February 17, 2023 | 3rd Party Submission

University of Maryland, Baltimore U.S. Patent Application, Porta Sophia Files Third Party Submission

Psychedelic prior art library presents three documents challenging patentability of all claims

January 30, 2023 | Press Release

Porta Sophia Responds to USPTO Request for Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights

January 23, 2023 | 3rd Party Observation

Universitätsspital Basel Patent Application, Porta Sophia Files Third Party Observation

Psychedelic prior art library presents 14 documents challenging patentability of all application claims

January 20, 2023 | 3rd Party Submission

University of Basel Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 13 documents challenging patentability of all application claims

January 12, 2023 | 3rd Party Submission

Arbormentis LLC U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 26 documents challenging patentability of all claims

January 6, 2023 | 3rd Party Submission

Mind Medicine Inc. U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents seven documents challenging patentability of all claims

December 15, 2022 | 3rd Party Submission

Turtle Bear Holdings U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents five documents challenging patentability of all claims

December 14, 2022 | Press Release

All Claims of Pharma America Holding US Patent Application Describing MDMA in Combination with Viagra® Rejected

USPTO directly cites prior art included in Porta Sophia's third-party preissuance submission in establishing application's lack of novelty

November 23, 2022 | 3rd Party Submission

Shawn Joseph U.S. Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 10 documents challenging patentability of all application claims

November 23, 2022 | 3rd Party Observation

Mynd Life Sciences International Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 2 documents challenging patentability of all application claims

November 22, 2022 | 3rd Party Observation

Compass Pathfinder Limited Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 4 documents challenging patentability of 38 of 52 claims

November 1, 2022 | 3rd Party Observation

GoodCap Pharmaceuticals Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 16 documents challenging patentability of all application claims

October 5, 2022 | Press Release

Yale Patent Application Claims Rejected as Unpatentable Based on References Submitted to the USPTO by Porta Sophia

August 25, 2022 | Press Release

COMPASS Pathways Amends Claims of US Patent Application Describing Psilocybin for the Treatment of Depression

Psychedelic drug company submits revised, narrower set of claims five months after Porta Sophia’s third-party preissuance submission challenged patentability

August 23, 2022 | 3rd Party Observation

Wesana Health International Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 5 documents challenging patentability of 105 claims

July 22, 2022 | 3rd Party Submission

CaaMTech U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 9 documents challenging patentability of all claims

July 22, 2022 | 3rd Party Submission

Pharma America Holding Inc. U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 9 documents challenging patentability of all claims

July 22, 2022 | 3rd Party Submission

Diamond Therapeutics Inc. U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 8 documents challenging patentability of all claims

June 16, 2022 | 3rd Party Submission

GH Research Ireland Limited U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 23 documents challenging patentability of all claims

June 7, 2022 | 3rd Party Submission

Turtle Bear Holdings LLC U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 8 documents challenging patentability of all claims

April 14, 2022 | 3rd Party Submission

University of Basel Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 21 documents challenging patentability of all claims of University of Basel application

April 5, 2022 | 3rd Party Submission

Pike Therapeutics Inc. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 23 documents challenging patentability of all claims of Pike Therapeutics Inc. application

March 9, 2022 | 3rd Party Submission

COMPASS Pathways Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 39 documents challenging patentability of all claims of COMPASS Pathways application

February 23, 2022 | 3rd Party Submission

Porta Sophia Files Third-Party Preissuance Submission For Patent Application Filed By Yale University and the US Department of Veterans Affairs

Psychedelic prior art library presents five documents challenging patentability of all claims of the application filed by co-applicants Yale University and The United States of America as represented by the Department of Veterans Affairs

December 16, 2021 | 3rd Party Submission

CaaMTech Inc. Cancels All Claims of US Patent Application Describing Serotonergic Drug Combinations

Psychedelic drug company submits revised, narrower set of claims within a month of Porta Sophia’s third-party preissuance submission challenging patentability

November 19, 2021 | 3rd Party Submission

Porta Sophia Files Third-Party Preissuance Submission For CaaMTech Inc. Patent Application

Psychedelic prior art library presents 18 documents challenging patentability of all claims of CaaMTech Inc. application